197 related articles for article (PubMed ID: 34895333)
1. Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin.
Šimčíková D; Gardáš D; Hložková K; Hruda M; Žáček P; Rob L; Heneberg P
Cancer Metab; 2021 Dec; 9(1):41. PubMed ID: 34895333
[TBL] [Abstract][Full Text] [Related]
2. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
3. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
4. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
[TBL] [Abstract][Full Text] [Related]
5. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
Cancer Metab; 2018; 6():7. PubMed ID: 29988332
[TBL] [Abstract][Full Text] [Related]
6. Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin.
Xu S; Catapang A; Doh HM; Bayley NA; Lee JT; Braas D; Graeber TG; Herschman HR
J Nucl Med; 2018 Jun; 60(2):212-7. PubMed ID: 29880505
[TBL] [Abstract][Full Text] [Related]
7. An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1
Xu S; Zhou T; Doh HM; Trinh KR; Catapang A; Lee JT; Braas D; Bayley NA; Yamada RE; Vasuthasawat A; Sasine JP; Timmerman JM; Larson SM; Kim Y; MacLeod AR; Morrison SL; Herschman HR
Cancer Res; 2019 May; 79(10):2748-2760. PubMed ID: 30885978
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.
Garcia SN; Guedes RC; Marques MM
Curr Med Chem; 2019; 26(41):7285-7322. PubMed ID: 30543165
[TBL] [Abstract][Full Text] [Related]
9. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
[TBL] [Abstract][Full Text] [Related]
10. AKT1 Promotes Tumorigenesis and Metastasis by Directly Phosphorylating Hexokinases.
Yu Y; Wang S; Wang Y; Zhang Q; Zhao L; Wang Y; Wu J; Han L; Wang J; Guo J; Xue J; Dong F; Zhang JH; Zhang L; Liu Y; Shi G; Zhang X; Li Y; Li J
J Cell Biochem; 2024 Jun; ():. PubMed ID: 38860522
[TBL] [Abstract][Full Text] [Related]
11. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.
DeWaal D; Nogueira V; Terry AR; Patra KC; Jeon SM; Guzman G; Au J; Long CP; Antoniewicz MR; Hay N
Nat Commun; 2018 Jan; 9(1):446. PubMed ID: 29386513
[TBL] [Abstract][Full Text] [Related]
12. Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1.
Magalhães RSS; Boechat FC; Brasil AA; Neto JRM; Ribeiro GD; Paranhos LH; Neves de Souza N; Vieira T; Outeiro TF; Neves BC; Eleutherio ECA
J Cell Biochem; 2022 Nov; 123(11):1808-1816. PubMed ID: 35944097
[TBL] [Abstract][Full Text] [Related]
13. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
14. Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target.
Ferreira JC; Khrbtli AR; Shetler CL; Mansoor S; Ali L; Sensoy O; Rabeh WM
J Biol Chem; 2021; 296():100071. PubMed ID: 33187984
[TBL] [Abstract][Full Text] [Related]
15. Spermatogenic cell-specific type 1 hexokinase is the predominant hexokinase in sperm.
Nakamura N; Shibata H; O'Brien DA; Mori C; Eddy EM
Mol Reprod Dev; 2008 Apr; 75(4):632-40. PubMed ID: 17924400
[TBL] [Abstract][Full Text] [Related]
16. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
Bustamante MF; Oliveira PG; Garcia-Carbonell R; Croft AP; Smith JM; Serrano RL; Sanchez-Lopez E; Liu X; Kisseleva T; Hay N; Buckley CD; Firestein GS; Murphy AN; Miyamoto S; Guma M
Ann Rheum Dis; 2018 Nov; 77(11):1636-1643. PubMed ID: 30061164
[TBL] [Abstract][Full Text] [Related]
17. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.
Wolf A; Agnihotri S; Micallef J; Mukherjee J; Sabha N; Cairns R; Hawkins C; Guha A
J Exp Med; 2011 Feb; 208(2):313-26. PubMed ID: 21242296
[TBL] [Abstract][Full Text] [Related]
18. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
Zhang J; Wang S; Jiang B; Huang L; Ji Z; Li X; Zhou H; Han A; Chen A; Wu Y; Ma H; Zhao W; Zhao Q; Xie C; Sun X; Zhou Y; Huang H; Suleman M; Lin F; Zhou L; Tian F; Jin M; Cai Y; Zhang N; Li Q
Nat Commun; 2017 Jan; 8():13732. PubMed ID: 28054552
[TBL] [Abstract][Full Text] [Related]
19. Selective knockdown of hexokinase 2 in rods leads to age-related photoreceptor degeneration and retinal metabolic remodeling.
Zhang R; Shen W; Du J; Gillies MC
Cell Death Dis; 2020 Oct; 11(10):885. PubMed ID: 33082308
[TBL] [Abstract][Full Text] [Related]
20. The intersection of metabolism and inflammation is governed by the intracellular topology of hexokinases and the metabolic fate of glucose.
Codocedo JF; Landreth GE
Immunometabolism (Cobham); 2022 Oct; 4(4):e00011. PubMed ID: 36337735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
